mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.058 |
0.7 |